Zhao Ning, Li Jian, Li Li, Niu Xu-yan, Jiang Miao, He Xiao-juan, Bian Zhao-xiang, Zhang Ge, Lu Ai-ping
Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China.
School of Basic Medical Sciences, Beijing University of Chinese Medicine, Beijing 100029, China.
Acta Pharmacol Sin. 2015 Jun;36(6):716-23. doi: 10.1038/aps.2015.15. Epub 2015 Apr 27.
Guizhi-shaoyao-zhimu decoction (GSZ), a traditional Chinese medicine (TCM) herbal formula, has been shown effective in the treatment of diabetic peripheral neuropathy (DPN). In this study, network analysis was performed to decipher the molecular mechanisms of GSZ in the treatment of DPN.
The chemical components of the 3 herbs forming GSZ, ie, Ramulus Cinnamomi (Guizhi), Paeonia lactiflora (Shaoyao) and Rhizoma Anemarrhenae (Zhimu), were searched in Chinese medicine dictionaries, and their target proteins were identified in PubChem. DPN genes were searched in PubMed gene databases. Ingenuity Pathway Analysis (IPA) was used to build the GSZ pharmacological network and DPN molecular network. The canonical pathways between the two networks were compared to decipher the molecular mechanisms of GSZ in the treatment of DPN.
Sixty-one protein targets for Guizhi, 31 targets for Shaoyao, 47 targets for Zhimu, as well as 23 genes related to DPN were identified and uploaded to IPA. The primary functions of the DPN molecular network were inflammatory response, metabolic disease, cellular assembly and organization. As far as the pharmacological network functions were concerned, Guizhi target proteins were involved in neurological disease, inflammatory disease, cellular growth and proliferation, cell signaling, molecular transport, and nucleic acid metabolism, Shaoyao target proteins were related to neurological disease, inflammatory disease, and Zhimu target proteins focused on cell death and survival, cellular movement, immune cell trafficking, DNA replication, recombination and repair, and cell cycle. In the three-herb combination GSZ, several new network functions were revealed, including the inflammatory response, gene expression, connective tissue development and function, endocrine system disorders, and metabolic disease. The canonical pathway comparison showed that Shaoyao focused on IL-12 signaling and production in macrophages, and Zhimu focused on TNFR2 signaling, death receptor signaling, ILK signaling, IL-17A in gastric cells, IL-6 signaling, IL-8 signaling, the role of JAK1, JAK2, and TYK2 in interferon signaling, IL-9 signaling, HMGB1 signaling, NO production and ROS production in macrophages, whereas GSZ focused aryl hydrocarbon receptor signaling and apoptosis signaling in addition to those pathways induced by Guizhi, Shaoyao and Zhimu.
Although each single herb can affect some DPN-related functions and pathways, GSZ exerts more effects on DPN-related functions and pathways. The effects of GSZ on aryl hydrocarbon receptor signaling and apoptosis signaling pathways may be the key components of its total molecular mechanisms.
桂枝芍药知母汤(GSZ)是一种中药复方,已被证明对糖尿病周围神经病变(DPN)的治疗有效。在本研究中,进行网络分析以阐明GSZ治疗DPN的分子机制。
在中国医药词典中搜索组成GSZ的三味中药,即桂枝(Ramulus Cinnamomi)、芍药(Paeonia lactiflora)和知母(Rhizoma Anemarrhenae)的化学成分,并在PubChem中鉴定其靶蛋白。在PubMed基因数据库中搜索DPN相关基因。使用Ingenuity Pathway Analysis(IPA)构建GSZ药理网络和DPN分子网络。比较两个网络之间的经典通路,以阐明GSZ治疗DPN的分子机制。
鉴定出桂枝的61个蛋白靶点、芍药的31个靶点、知母的47个靶点以及23个与DPN相关的基因,并上传至IPA。DPN分子网络的主要功能是炎症反应、代谢性疾病、细胞组装和组织。就药理网络功能而言,桂枝靶蛋白参与神经疾病、炎症性疾病、细胞生长和增殖、细胞信号传导、分子运输和核酸代谢,芍药靶蛋白与神经疾病、炎症性疾病相关,知母靶蛋白主要集中在细胞死亡与存活、细胞运动、免疫细胞运输、DNA复制、重组和修复以及细胞周期。在三味药组成的GSZ中,揭示了几种新的网络功能,包括炎症反应、基因表达、结缔组织发育和功能、内分泌系统紊乱和代谢性疾病。经典通路比较表明,芍药主要集中在巨噬细胞中IL-12信号传导和产生,知母主要集中在TNFR2信号传导、死亡受体信号传导、ILK信号传导、胃细胞中IL-17A、IL-6信号传导、IL-8信号传导、JAK1、JAK2和TYK2在干扰素信号传导中的作用、IL-9信号传导、HMGB1信号传导、巨噬细胞中NO产生和ROS产生,而GSZ除了桂枝、芍药和知母诱导的那些通路外,还集中在芳烃受体信号传导和凋亡信号传导。
虽然每一味单药都能影响一些与DPN相关的功能和通路,但GSZ对与DPN相关的功能和通路有更多影响。GSZ对芳烃受体信号传导和凋亡信号传导通路的影响可能是其整体分子机制的关键组成部分。